A carregar...

State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019

Abstract Experience in the use of CAR T cells to treat CLL is limited, but safety and efficacy data are encouraging, suggesting that it may be possible to use CAR T cells in populations of CLL patients with particularly unfavorable prognoses. Mechanisms intrinsic to the pathophysiology of CLL undoub...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Richard Lemal, Olivier Tournilhac
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019-08-01
Colecção:Journal for ImmunoTherapy of Cancer
Assuntos:
CLL
Acesso em linha:http://link.springer.com/article/10.1186/s40425-019-0686-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!